Victory Capital Management Inc Unity Biotechnology, Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$0.4 - $4.27 $5,604 - $59,822	14,010 New	14,010 $6,000
Q2 2020 Aug 07, 2020	SELL	$5.28 - $9.67 $17,228 - $31,553	-3,263 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$5.0 - $7.6 $775 - $1,178	-155 Reduced 4.53%	3,263 $19,000
Q4 2019 Feb 04, 2020	SELL	$5.99 - $8.38 $347 - $486	-58 Reduced 1.67%	3,418 $20,000
Q3 2019 Nov 12, 2019	BUY	$5.62 - $9.63 $19,535 - $33,473	3,476 New	3,476 $21,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.